Literature DB >> 11210864

Botulinum toxin: basic science and clinical uses in otolaryngology.

A Blitzer1, L Sulica.   

Abstract

The role of botulinum toxin as a therapeutic agent is expanding rapidly in otolaryngology. Botulinum toxin is a protease that blocks the release of acetylcholine from nerve terminals. Its effects are transient and nondestructive, and largely limited to the area in which it is administered. These effects are also graded according to dose, allowing for individualized treatment of patients and disorders. Botulinum toxin has been used primarily to treat disorders of excessive or inappropriate muscle contraction. In the field of otolaryngology, these include spasmodic dysphonia, oromandibular dystonia, and blepharospasm; vocal tics and stuttering; cricopharyngeal achalasia; various tremors and tics; hemifacial spasm; temporomandibular joint disorders; and a number of cosmetic applications. Botulinum toxin treatment has recently begun to show some benefit in the control of pain from migraine and tension headache. It may also prove useful in the control of autonomic dysfunction, as in Frey syndrome, sialorrhea, and rhinorrhea. In over 20 years of use in humans, botulinum toxin has accumulated a considerable safety record, and in many cases represents relief for thousands of patients unaided by other therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11210864     DOI: 10.1097/00005537-200102000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  16 in total

Review 1.  ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  M Ptok; R Schönweiler; T Nawka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

2.  [Use of botulinum toxin in ORL departments in Germany].

Authors:  P Matthes; J Kruegel; C Karapantzou; J Winterhoff; R Laskawi
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

3.  Accessory nerve distribution for aesthetic botulinum toxin injections into the upper trapezius muscle: anatomical study and clinical trial : Reproducible BoNT injection sites for upper trapezius.

Authors:  Jung-Hee Bae; Ji-Soo Lee; Da-Yae Choi; JeongHoon Suhk; Seong Taek Kim
Journal:  Surg Radiol Anat       Date:  2018-06-26       Impact factor: 1.246

4.  Anatomical recommendations for safe botulinum toxin injection into temporalis muscle: a simplified reproducible approach.

Authors:  Won-Kang Lee; Jung-Hee Bae; Kyung-Seok Hu; Takafumi Kato; Seong-Taek Kim
Journal:  Surg Radiol Anat       Date:  2016-09-08       Impact factor: 1.246

5.  Post-surgical role of botulinum toxin-A injection in patients with head and neck cancer: personal experience.

Authors:  M R Marchese; G Almadori; A Giorgio; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-02       Impact factor: 2.124

Review 6.  Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.

Authors:  C R Watts; D D Truong; C Nye
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

7.  [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].

Authors:  O Guntinas-Lichius
Journal:  HNO       Date:  2003-06-17       Impact factor: 1.284

8.  Botulinum toxin in the management of dystonia.

Authors:  Omar D Cardona-Garcia; Donald S Higgins; Eric S Molho
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

Review 9.  Efficacy of botulinum toxins on bruxism: an evidence-based review.

Authors:  Hu Long; Zhengyu Liao; Yan Wang; Lina Liao; Wenli Lai
Journal:  Int Dent J       Date:  2012-02       Impact factor: 2.607

Review 10.  Botulinum toxin injections for the treatment of spasmodic dysphonia.

Authors:  C C W Watts; R Whurr; C Nye
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.